{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T06:03:53Z","timestamp":1779861833042,"version":"3.53.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejps.2026.107546","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:45:57Z","timestamp":1777941957000},"page":"107546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Contamination of ophthalmic solutions by 2,4-Di\u2011tert-butylphenol: an evaluation of leachability and in vitro cytotoxicity"],"prefix":"10.1016","volume":"222","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1046-9905","authenticated-orcid":false,"given":"Marion","family":"Barrieu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Othylie","family":"Allard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Sautou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8086-7517","authenticated-orcid":false,"given":"Philip","family":"Chennell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejps.2026.107546_bib0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics14010118","article-title":"Physicochemical stability of a novel tacrolimus ophthalmic formulation for the treatment of ophthalmic inflammatory diseases","volume":"14","author":"Barrieu","year":"2022","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.ejps.2026.107546_bib0017","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1208\/s12248-025-01124-8","article-title":"Investigation of 2,4 di-tert-butylphenol leaching from multidose ophthalmic devices into Tacrolimus Micellar formulations","volume":"27","author":"Barrieu","year":"2025","journal-title":"AAPS. J."},{"issue":"6","key":"10.1016\/j.ejps.2026.107546_bib0026","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.chemosphere.2013.06.043","article-title":"Low dose effects and non-monotonic dose responses for endocrine active chemicals: science to practice workshop: workshop summary","volume":"93","author":"Beausoleil","year":"2013","journal-title":"Chemosphere"},{"issue":"8","key":"10.1016\/j.ejps.2026.107546_bib0032","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12080781","article-title":"Stability of ophthalmic atropine solutions for child myopia control","volume":"12","author":"Berton","year":"2020","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.ejps.2026.107546_bib0031","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0181-5512(07)92614-5","article-title":"Stabilit\u00e9 \u00e0 \u201320 \u00b0C des collyres antibiotiques renforc\u00e9s (amikacine, ceftazidime, vancomycine)","volume":"30","author":"Ch\u00e9dru-Legros","year":"2007","journal-title":"J. Fr. Ophtalmol."},{"key":"10.1016\/j.ejps.2026.107546_bib0029","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejps.2017.01.024","article-title":"Stability of an ophthalmic micellar formulation of cyclosporine A in unopened multidose eyedroppers and in simulated use conditions","volume":"100","author":"Chennell","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107546_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119332","article-title":"Leachables from plastic materials in contact with drugs. State of the art and review of current analytical approaches","volume":"583","author":"Cuadros-Rodr\u00edguez","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107546_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2024.177999","article-title":"Remediation of a diesel contaminated soil by means of anionic and non-ionic surfactants: effect on soil phosphorus availability and Vicia Faba L. growth","volume":"958","author":"De Marines","year":"2025","journal-title":"Sci. Total. Environ."},{"key":"10.1016\/j.ejps.2026.107546_bib0056","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.chemosphere.2017.01.026","article-title":"In vitro cytotoxic effects of DEHP-alternative plasticizers and their primary metabolites on a L929 cell line","volume":"173","author":"Eljezi","year":"2017","journal-title":"Chemosphere"},{"issue":"13","key":"10.1016\/j.ejps.2026.107546_bib0036","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0959-8049(01)00171-X","article-title":"Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation","volume":"37","author":"Gelderblom","year":"2001","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.ejps.2026.107546_bib0002","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41433-021-01668-x","article-title":"Ocular benzalkonium chloride exposure: problems and solutions","volume":"36","author":"Goldstein","year":"2022","journal-title":"Eye"},{"issue":"10","key":"10.1016\/j.ejps.2026.107546_bib0066","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1016\/j.xphs.2019.06.009","article-title":"Identification of an adduct impurity of an active pharmaceutical ingredient and a leachable in an ophthalmic drug product using LC-QTOF","volume":"108","author":"Gollapalli","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107546_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.105880","article-title":"Inhalation of 2, 4-di-tert-butylphenol-loaded micelles suppresses respiratory syncytial virus infection in mice","volume":"226","author":"Guo","year":"2024","journal-title":"Antiviral Res."},{"issue":"3","key":"10.1016\/j.ejps.2026.107546_bib0047","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1139\/v66-039","article-title":"The oxidation of phenols: II. The oxidation of 2,4-DI-t-Butylphenol with Peroxy radicals","volume":"44","author":"Horswill","year":"1966","journal-title":"Can. J. Chem."},{"issue":"3","key":"10.1016\/j.ejps.2026.107546_bib0013","doi-asserted-by":"crossref","first-page":"278","DOI":"10.5731\/pdajpst.2022.012744","article-title":"Principles for management of extractables and leachables in ophthalmic drug products","volume":"76","author":"Houston","year":"2022","journal-title":"PDa J. Pharm. Sci. Technol."},{"issue":"2","key":"10.1016\/j.ejps.2026.107546_bib0012","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5731\/pdajpst.2016.007229","article-title":"Simulated leaching (Migration) study for a model container-closure system applicable to parenteral and ophthalmic drug products","volume":"71","author":"Jenke","year":"2017","journal-title":"PDa J. Pharm. Sci. Technol."},{"issue":"21","key":"10.1016\/j.ejps.2026.107546_bib0040","doi-asserted-by":"crossref","first-page":"7606","DOI":"10.3390\/molecules27217606","article-title":"Ultrasound-assisted water extraction of gentiopicroside, isogentisin, and polyphenols from Willow gentian \u201cdust\u201d supported by hydroxypropyl-\u03b2-cyclodextrin as cage molecules","volume":"27","author":"Jovanovi\u0107","year":"2022","journal-title":"Molecules."},{"key":"10.1016\/j.ejps.2026.107546_bib0057","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejps.2017.03.018","article-title":"HCE-T cell-based permeability model: a well-maintained or a highly variable barrier phenotype?","volume":"104","author":"Jureti\u0107","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"issue":"11","key":"10.1016\/j.ejps.2026.107546_bib0019","doi-asserted-by":"crossref","first-page":"6572","DOI":"10.1007\/s12010-023-04403-2","article-title":"A novel finding: 2,4-di-tert-butylphenol from Streptomyces bacillaris ANS2 effective against mycobacterium tuberculosis and cancer cell lines","volume":"195","author":"Kaari","year":"2023","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"1","key":"10.1016\/j.ejps.2026.107546_bib0037","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ijpharm.2005.01.011","article-title":"Investigation of the release behavior of DEHP from infusion sets by paclitaxel-loaded polymeric micelles","volume":"293","author":"Kim","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2026.107546_bib0039","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jenvman.2017.05.037","article-title":"Surfactant-enhanced remediation of polycyclic aromatic hydrocarbons: a review","volume":"199","author":"Lamichhane","year":"2017","journal-title":"J. Environ. Manage"},{"issue":"1","key":"10.1016\/j.ejps.2026.107546_bib0025","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1079\/PNS2005478","article-title":"Developmental programming of health and disease","volume":"65","author":"Langley-Evans","year":"2006","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.ejps.2026.107546_bib0048","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.envpol.2019.06.077","article-title":"Unexpectedly high concentrations of 2,4-di-tert-butylphenol in human urine","volume":"252","author":"Liu","year":"2019","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.ejps.2026.107546_bib0042","series-title":"Practical Pharmaceutics: An International Guideline for the Preparation, Care and Use of Medicinal Products [Internet]","first-page":"163","article-title":"Eye","author":"Ludwig","year":"2015"},{"issue":"16","key":"10.1016\/j.ejps.2026.107546_bib0020","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1080\/14786419.2018.1531406","article-title":"Anti-inflammatory and anticancer activities of erythrodiol-3-acetate and 2,4-di-tert-butylphenol isolated from Humboldtia unijuga","volume":"34","author":"Nair","year":"2020","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.ejps.2026.107546_bib0004","author":"Nehar-Cohen"},{"key":"10.1016\/j.ejps.2026.107546_bib0011","unstructured":"Nemera La Verpilli\u00e8re, France. Novelia: preservative-free Multi-dose eye dropper - product performance and microbiological package. 2016."},{"issue":"3","key":"10.1016\/j.ejps.2026.107546_bib0053","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0181-5512(06)73780-9","article-title":"\u00c9tude de la cytotoxicit\u00e9 de diff\u00e9rents collyres \u00e0 base de ciclosporine A buvable (Sandimmun\u00ae)","volume":"29","author":"Nourry","year":"2006","journal-title":"J. Fr. Ophtalmol."},{"issue":"4","key":"10.1016\/j.ejps.2026.107546_bib0055","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2174\/1871520621999201230202614","article-title":"Different methods for cell viability and proliferation assay: essential tools in pharmaceutical studies","volume":"22","author":"Nozhat","year":"2022","journal-title":"AntiCancer Agents Med. Chem."},{"issue":"5","key":"10.1016\/j.ejps.2026.107546_bib0052","doi-asserted-by":"crossref","first-page":"430","DOI":"10.5731\/pdajpst.2013.00936","article-title":"The product quality research institute (PQRI) leachables and extractables working group initiatives for parenteral and ophthalmic drug Product (PODP)","volume":"67","author":"Paskiet","year":"2013","journal-title":"PDa J. Pharm. Sci. Technol."},{"issue":"4","key":"10.1016\/j.ejps.2026.107546_bib0059","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1167\/iovs.08-2992","article-title":"Multiple endpoint analysis of the 3D-reconstituted corneal epithelium after treatment with benzalkonium chloride: early detection of toxic damage","volume":"50","author":"Pauly","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejps.2026.107546_bib0043","series-title":"Surface oculaire: Rapport 2015 [pr\u00e9sent\u00e9 \u00e0 la] Soci\u00e9t\u00e9 fran\u00e7aise D\u2019ophtalmologie","author":"Pisella","year":"2015"},{"key":"10.1016\/j.ejps.2026.107546_bib0054","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105906","article-title":"Formulation of olopatadine hydrochloride viscous eye drops \u2013 physicochemical, biopharmaceutical and efficacy assessment using in vitro and in vivo approaches","volume":"166","author":"Ra\u010di\u0107","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107546_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105102","article-title":"Stability of frozen 1% voriconazole eye-drops in both glass and innovative containers","volume":"141","author":"Roche","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107546_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2021.03.026","article-title":"Efficacy of medical treatments for vernal keratoconjunctivitis: a systematic review and meta-analysis","author":"Roumeau","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"issue":"8","key":"10.1016\/j.ejps.2026.107546_bib0058","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1023\/A:1011956327987","article-title":"Evaluation of cytotoxicity of various ophthalmic drugs, eye drop excipients and cyclodextrins in an immortalized human corneal epithelial cell line","volume":"15","author":"Saarinen-Savolainen","year":"1998","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ejps.2026.107546_bib0045","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00216-025-06217-z","article-title":"Human biomonitoring of 2,4-di-tert-butylphenol: determination of the parent substance and a novel, specific metabolite in urine by UHPLC-MS\/MS","volume":"418","author":"Schmidtkunz","year":"2026","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.ejps.2026.107546_bib0006","series-title":"Nemera Eyedroppers Designed For Patients","first-page":"16","author":"Sellier","year":"2018"},{"issue":"1","key":"10.1016\/j.ejps.2026.107546_bib0063","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/02713683.2024.2385442","article-title":"Autologous serum eye drops diluted with cyclosporine A 0.05% and sodium hyaluronate 0.1%: an experimental comparative study","volume":"50","author":"Sharma","year":"2025","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ejps.2026.107546_bib0065","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jpba.2018.01.053","article-title":"Identification of leachable impurities in an ophthalmic drug product originating from a polymer additive Irganox 1010 using mass spectroscopy","volume":"152","author":"Singh","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"3","key":"10.1016\/j.ejps.2026.107546_bib0067","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/10837450.2017.1365370","article-title":"Profiling extractable and leachable inorganic impurities in ophthalmic drug containers by ICP-MS","volume":"23","author":"Solomon","year":"2018","journal-title":"Pharm. Dev. Technol."},{"issue":"10","key":"10.1016\/j.ejps.2026.107546_bib0062","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1089\/jop.2024.0085","article-title":"The optejet technology minimizes preservative-mediated cytotoxicity of conjunctival epithelial cells treated with latanoprost In vitro","volume":"40","author":"Sultan","year":"2024","journal-title":"J. Ocul. Pharmacol. Ther. Off J. Assoc. Ocul. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.ejps.2026.107546_bib0005","doi-asserted-by":"crossref","DOI":"10.1097\/IJG.0000000000000020","article-title":"Safety and efficacy of benzalkonium chloride-optimized tafluprost in Japanese glaucoma patients with existing superficial punctate keratitis","volume":"24","author":"Suzuki","year":"2015","journal-title":"J. Glaucoma"},{"issue":"2","key":"10.1016\/j.ejps.2026.107546_bib0041","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ejpb.2004.03.033","article-title":"The potential of lipid emulsion for ocular delivery of lipophilic drugs","volume":"58","author":"Tamilvanan","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"6","key":"10.1016\/j.ejps.2026.107546_bib0060","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s00204-021-03036-w","article-title":"The in vitro assessment of the toxicity of volatile, oxidisable, redox-cycling compounds: phenols as an example","volume":"95","author":"Tolosa","year":"2021","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejps.2026.107546_bib0015","series-title":"Guidance For Industry: Container Closure Systems for Packaging Human Drugs and Biologics [Internet]","year":"1999"},{"key":"10.1016\/j.ejps.2026.107546_bib0035","series-title":"Encyclopedia of Industrial chemistry, 5th Edition [Internet]","year":"1991"},{"key":"10.1016\/j.ejps.2026.107546_bib0016","doi-asserted-by":"crossref","unstructured":"United States Pharmacopeia General Chapter 1664. United States Pharmacopeia USP <1664> assessment of drug product leachables associated with pharmaceutical packaging\/Delivery systems. [Internet]. 2024. Available from: https:\/\/doi.org\/10.31003\/USPNF_M7127_04_01.","DOI":"10.31003\/USPNF_M7127_04_01"},{"key":"10.1016\/j.ejps.2026.107546_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112415","article-title":"Butylated hydroxyl-toluene, 2,4-Di-tert-butylphenol, and phytol of Chlorella sp. protect the PC12 cell line against H2O2-induced neurotoxicity","volume":"145","author":"Vahdati","year":"2022","journal-title":"Biomed. PharmacOther"},{"issue":"11","key":"10.1016\/j.ejps.2026.107546_bib0068","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1134\/S1061934814110136","article-title":"Migration study of zinc dibutyldithiocarbamate in eye drops solutions","volume":"69","author":"Vardakou","year":"2014","journal-title":"J. Anal. Chem."},{"key":"10.1016\/j.ejps.2026.107546_bib0003","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.toxlet.2019.10.014","article-title":"Benzalkonium chloride-induced direct and indirect toxicity on corneal epithelial and trigeminal neuronal cells: proinflammatory and apoptotic responses in vitro","volume":"319","author":"Vitoux","year":"2020","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejps.2026.107546_bib0046","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cej.2016.06.092","article-title":"Degradation kinetics and mechanism of 2,4-Di-tert-butylphenol with UV\/persulfate","volume":"304","author":"Wang","year":"2016","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.ejps.2026.107546_bib0061","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tox.2014.11.003","article-title":"An overview of current techniques for ocular toxicity testing","volume":"327","author":"Wilson","year":"2015","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.ejps.2026.107546_bib0023","doi-asserted-by":"crossref","DOI":"10.3390\/toxins12010035","article-title":"Natural sources and bioactivities of 2,4-Di-Tert-Butylphenol and Its Analogs","volume":"12","author":"Zhao","year":"2020","journal-title":"Toxins. (Basel)"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809872600120X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809872600120X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T05:17:43Z","timestamp":1779859063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092809872600120X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":54,"alternative-id":["S092809872600120X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107546","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contamination of ophthalmic solutions by 2,4-Di\u2011tert-butylphenol: an evaluation of leachability and in vitro cytotoxicity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107546","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107546"}}